Collection 專利 [0/3] 會議論文/會議摘要 [0/2] 期刊論文 [21/21] Siblings 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 謝興邦 [171/231] 趙宇生(2002-2013) [120/212] 郭靜娟 [49/55] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 陳炯東 [180/212] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:3(11.54%) 含全文筆數:21(80.77%) 文件下載次數統計 下載大於0次:21(100.00%) 下載大於100次:19(90.48%) 檔案下載總次數:12149(0.23%) 最後更新時間: 2024-12-01 03:19 Top Upload Loading... Top Download Loading... Recent Submissions Discovery of a long half-life AURKA... Pulmonary delivery of remdesivir an... Modulating the affinity and signali... Synergistic inhibition of SARS-CoV-... Discovery and synthesis of a pyrimi... Synergistic inhibition of SARS-CoV-... BPR6K609: An Aurora kinase inhibito... Inhibition of SARS-CoV-2 by highly ... Comparative study between deep lear... An Aurora kinase inhibitor BPR6K471...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 26. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2024-06-01	Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus	Molecular Cancer Therapeutics. 2024 Jun 01;23(6):766-779.
2023-12	Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced inflammatory suppression in lung	Journal of Drug Delivery Science and Technology. 2023 Dec;90:Article number 105144.
2023-01	Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists	Bioorganic Chemistry. 2023 Jan;130:Article number 106236.
2021-06-11	Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir[Erratum:ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.]	ACS Pharmacology and Translational Science. 2021 Jun 11;4(3):Article number 1246.
2021-05-19	Discovery and synthesis of a pyrimidine-based aurora kinase inhibitor to reduce levels of MYC oncoproteins	Journal of Medicinal Chemistry. 2021 May 19;64(11):7312-7330.
2021-04-09	Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir	ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.
2020-12-14	Inhibition of SARS-CoV-2 by highly potent broad-spectrum anti-coronaviral tylophorine-based derivatives	Frontiers in Pharmacology. 2020 Dec 14;11:Article number 606097.
2020-10-08	Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery	Scientific Reports. 2020 Oct 8;10:Article number 16771.
2020-08	BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification	Cancer Research. 2020 Aug;80(16):1937.
2019-07	An Aurora kinase inhibitor BPR6K471 inhibits tumor growth and reduces the cancer stem cell-like properties of small cell lung cancer	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 3851.
2019-01-01	Fluorine-18 isotope labeling for positron emission tomography imaging. Direct evidence for DBPR211 as a peripherally restricted CB1 inverse agonist	Bioorganic and Medicinal Chemistry. 2019 Jan 1;27(1):216-223.
2018-05-10	Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition	European Journal of Medicinal Chemistry. 2018 May 10;151:533-545.
2016-12-08	Bromomethylthioindole inspired carbazole hybrids as promising class of anti-MRSA agents	ACS Medicinal Chemistry Letters. 2016 Dec 8;7(12):1191-1196.
2015-05	A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis	Diabetes, Obesity and Metabolism. 2015 May;17(5):495-504.
2015-03	Stem cell mobilizers targeting chemokine receptor CXCR4: Renoprotective application in acute kidney injury	Journal of Medicinal Chemistry. 2015 Mar;58(5):2315-2325.
2015-02-24	Pyrazole compounds	US8962845/2015-02-24
2015-02-11	吡唑類化合物	I472514/2015-02-11
2015-02	Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors	Journal of Medicinal Chemistry. 2015 Feb;58(3):1452-1465.
2014-07-30	Pyrazole compounds	ZA201303800B/2014-07-30
2013-11-13	Discovery of 1-(2,4-Dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5 -(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice	Journal of Medicinal Chemistry. 2013 Nov 13;56(24):9920-9933.
2012-07	Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors	International Journal of Obesity. 2012 Jul;36(7):999-1006.
2012-02	Discovery of novel stem cell mobilizers that target the CXCR4 receptor	ChemMedChem. 2012 Feb;7(2):209-212.
2011-07	Conia-ene annulation of the alpha-cyano Beta-TMS-capped alkynyl cycloalkanone system and its synthetic application	Organic and Biomolecular Chemistry. 2011 Jul;9(13):4778-4781.
2010-09	Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophe n-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist	ChemMedChem. 2010 Sep;5(9):1439-1443.
2009-07-23	Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice	Journal of Medicinal Chemistry. 2009 Jul 23;52(14):4496-4510.

Showing items 1-25 of 26. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page